Item request has been placed!
×
Item request cannot be made.
×
Processing Request
Are Antiemetics the Next Therapeutic Strategy against Cisplatin-Associated Acute Kidney Injury?
Item request has been placed!
×
Item request cannot be made.
×
Processing Request
- Additional Information
- Source:
Publisher: Wolters Kluwer Health, Inc. on behalf of the American Society of Nephrology Country of Publication: United States NLM ID: 101766381 Publication Model: Print Cited Medium: Internet ISSN: 2641-7650 (Electronic) Linking ISSN: 26417650 NLM ISO Abbreviation: Kidney360 Subsets: MEDLINE
- Publication Information:
Publication: 2023- : [Hagerstown, MD] : Wolters Kluwer Health, Inc. on behalf of the American Society of Nephrology
Original Publication: [Washington, DC] : American Society of Nephrology, [2020]-
- Subject Terms:
- References:
Sci Rep. 2021 Sep 30;11(1):19409. (PMID: 34593872)
J Intensive Care Med. 2022 Oct;37(10):1403-1410. (PMID: 35000482)
Clin Transl Sci. 2021 Sep;14(5):1906-1916. (PMID: 33982438)
J Crit Care. 2021 Dec;66:117-122. (PMID: 34509800)
Kidney360. 2024 Aug 1;5(8):1094-1100. (PMID: 38814726)
- Accession Number:
Q20Q21Q62J (Cisplatin)
0 (Antiemetics)
0 (Antineoplastic Agents)
- Publication Date:
Date Created: 20240829 Date Completed: 20240829 Latest Revision: 20240905
- Publication Date:
20240905
- Accession Number:
PMC11371336
- Accession Number:
10.34067/KID.0000000000000518
- Accession Number:
39207890
No Comments.